Santen Pharmaceutical Director of Finance Salaries in Baltimore, MD | Comparably
Santen is a Japanese pharmaceutical company specializing in the development and manufacturing of ophthalmic products read more
EMPLOYEE
PARTICIPANTS
12
TOTAL
RATINGS
132

Santen Pharmaceutical Director of Finance Salaries in Baltimore, MD

The average Santen Pharmaceutical Director of Finance in Baltimore, MD earns an estimated $138,033 annually. Santen Pharmaceutical's Director of Finance compensation is $23,983 less than the US average for a Director of Finance.

In Baltimore, MD, The Finance Department at Santen Pharmaceutical earns $2,307 more on average than the Business Development Department.

Last updated 4 years ago.

$30k
$74k
$117k
$159k
$350k
$600k
$138,033
Average Compensation
$138,033
avg. base

Director of Finance Salaries at Santen Pharmaceutical

In Baltimore, MD, Directors of Finance earn $26,706 more than Accounting Managers.

Accounting Manager
$111k*
Senior Accountant
$84k*
Business Analyst
$74k*
Financial Analyst
$72k*
Accountant
$66k*
* estimated salary

Compensation at Santen Pharmaceutical by Department

In Baltimore, MD, The Finance Department averages $2,307 more than the Business Development Department, and $4,841 less than the Legal Department

Legal
$83,550 Avg. total comp.
+$5k
Finance
$78,709 Avg. total comp.
Business Development
$76,402 Avg. total comp.
-$2k

Director of Finance Compensation by Gender (All Companies)

The average female Director of Finance at companies similar size to Santen Pharmaceutical reported making $169,182, while the average male Director of Finance at similar sized companies reported making $188,100.

Director of Finance Compensation by Ethnicity (All Companies)

The average Caucasian Director of Finance at companies similar size to Santen Pharmaceutical reported making $184,183, while the average Native American Director of Finance at similar sized companies reported making $30,000.

How Directors of Finance at Santen Pharmaceutical Rate Their Compensation

The majority of Directors of Finance at Santen Pharmaceutical believe they're not compensated fairly. 50% of Directors of Finance at Santen Pharmaceutical say they receive annual bonuses, and the majority (50%) are satisfied with their benefits. See more compensation ratings at Santen Pharmaceutical

×
Rate your company